Investigating the TLR4/TAK1/IRF7 axis in NLRP3-Mediated Pyroptosis in Parkinson's Disease
- 6 November 2023
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 47 (1) , 404-420
Abstract
In the realm of Parkinson's disease (PD) research, NLRP3 inflammasome-mediated pyroptosis has recently garnered significant attention as a potential novel form of dopaminergic neuronal death. Our previous research revealed the activation of innate immune-related genes, such as the TLR4 signaling pathway and interferon regulatory factor 7 (IRF7), although the specific mechanism remains unclear. Our current study shed light on whether the TLR4 signaling pathway and IRF7 can affect the pyroptosis of dopaminergic nerve cells and thus participate in the pathogenesis of PD. The PD model was constructed by MPP+ treatment of PC12 cells or stereotactic injection of the striatum of SD rats, and the expression of genes were detected by RT-qPCR and Western Blotting. Lentivirus, siRNA and (5Z)-7-Oxozeaenol were used to validate the regulation of this pathway on pyroptosis. The expression of TLR4, TAK1, IRF7 and pyroptosis molecular markers was upregulated after MPP+ treatment. IRF7 could affect dopaminergic neural cells pyroptosis by targeted regulation of NLRP3. Furthermore, inhibition of the TLR4/TAK1 signaling pathway led to a decrease in the expression of both IRF7 and NLRP3, while overexpression of IRF7 reversed the reduction in pyroptosis and increase in TH expression. TLR4/TAK1/IRF7 axis can promote PD by influencing pyroptosis through NLRP3.Keywords
Funding Information
- Science and Technology Department of Jilin Province (202522YY010472612)
- Jilin Province Center for Precision Medicine Diagnosis and Treatment of Nervous System Diseases (20200602045ZP)
- the Key R & D project of Science and Technology Department of Jilin Province (20210204109YY)
This publication has 61 references indexed in Scilit:
- Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson diseaseScientific Reports, 2013
- PINK1 stimulates interleukin-1β-mediated inflammatory signaling via the positive regulation of TRAF6 and TAK1Cellular and Molecular Life Sciences, 2012
- Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetesNature Immunology, 2010
- Proteomic identification of biomarkers in the cerebrospinal fluid in a rat model of nigrostriatal dopaminergic degenerationJournal of Neuroscience Research, 2007
- IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptorsNature Reviews Immunology, 2006
- Spatiotemporal regulation of MyD88–IRF-7 signalling for robust type-I interferon inductionNature, 2005
- IRF-7 is the master regulator of type-I interferon-dependent immune responsesNature, 2005
- Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signalingProceedings of the National Academy of Sciences, 2004
- Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6Nature Immunology, 2004
- Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's diseaseProceedings of the National Academy of Sciences of the United States of America, 2000